T1	Participants 643 680	enrolled 124 women 21-60 years of age
T2	Participants 797 805	patients
T3	Participants 1079 1096	paracetamol group
T4	Participants 1109 1123	placebo group.
T5	Participants 1307 1317	two groups
T6	Participants 1160 1177	paracetamol group
T7	Participants 1221 1234	placebo group
T8	Participants 1414 1427	placebo group
T9	Participants 1440 1458	paracetamol group.
T10	Participants 1558 1568	two groups
